Camptothecin and its analogues: a review on their chemotherapeutic potential.

Abstract

Topoisomerase I (Topo-I) is a major target for anticancer drug discovery and design. As a result, Topo-I inhibitors constitute an important class of the current anticancer drugs. To date, all of the Topo-I inhibitors that have been clinically evaluated are analogues of camptothecin (CPT), an extract of the Chinese tree Camptotheca acuminata. CPT has shown significant antitumor activity to lung, ovarian, breast, pancreas and stomach cancers. In this article the, phytochemical aspect, and various structural modifications are comprehensively reviewed as in rings A, B, C, D and E. Biological activity of camptothecin, other than anticancer, reported till the year 2003 has also been discussed.

0204060'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

202 Citations

Semantic Scholar estimates that this publication has 202 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sriram2005CamptothecinAI, title={Camptothecin and its analogues: a review on their chemotherapeutic potential.}, author={Dharmarajan Sriram and Perumal Yogeeswari and Rathinasabapathy Thirumurugan and Tanushree Ratan Bal}, journal={Natural product research}, year={2005}, volume={19 4}, pages={393-412} }